MedPath
HSA Approval

FLUDEOXYGLUCOSE [F18] INJECTION 5-200 mCi/mL

SIN13907P

FLUDEOXYGLUCOSE [F18] INJECTION 5-200 mCi/mL

FLUDEOXYGLUCOSE [F18] INJECTION 5-200 mCi/mL

January 7, 2011

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE RADIOPHARMACEUTICALS PTE. LTD.
Licence HolderSINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

V09IX04

fludeoxyglucose (18F)

Manufacturer Information

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

SINGAPORE RADIOPHARMACEUTICALS PTE. LTD.

Active Ingredients

2-deoxy-2-[18F]fluoro-D-glucose

5-200mCi/mL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FLUDEOXYGLUCOSE [F18] INJECTION 5-200 mCi/mL - HSA Approval | MedPath